IMPROVE Study Phase 2

Screeners for FDA IMPROVE Survey
ACP & AANP Eligibility Criteria

The eligibility screening process is conducted using a preexisting database before
participants are contacted via email and therefore bears no burden on participants. Both
AANP and ACP participants will be screened based on the following criteria:
1. Gender
[QUOTA: recruit representative mix. ]
2. Age

[QUOTA: 35-65 years]

3. US vs International Medical Graduate

[QUOTA: recruit a representative mix.]

4. Member class
• Member
• Fellow
• Master of the College
[QUOTA: recruit Members and Fellows. Masters do not see patients.]
5. Primary specialty.
[QUOTA: recruit Internal Medicine for broadest prescribing base.]
6.

Amount of time in direct patient care
• <25%
• 25-49%
• 50-74%
• 75%+
[QUOTA: recruit 50-74% and 75% participants.]

7. Location of patient care (inpatient vs. outpatient) [QUOTA: recruit outpatient.]

Sample Recruitment Email
Subject: You’ve been selected to participate in the 2016 IMPROVE Survey!
Your name has been selected to participate in the _____________, a nationwide survey being
conducted by the University of Chicago in collaboration with the FDA. This survey will
collect information to provide _________________. Please take twelve minutes and take this
survey online. Your participation in this survey is voluntary and you can exit at any time.
Whether or not you choose to participate will not affect your relationship with AANP/ACP.
Submission of this survey is considered implied consent. Your responses are confidential. If
you have any questions, please contact the AANP/ACP Research Department by email at
or by phone at .
Take me to the survey (active hyperlink)

Or copy and paste this URL into your internet browser:
Sample Informed Consent (beginning of survey)
The aim of this survey is to gather your opinions and perspectives on generic prescribing.
Please note that once you start the survey you cannot go back to questions you already
answered.
Your participation in this survey is voluntary and you can exit at any time. Submission of this
survey is considered implied consent. Any responses you provide will be confidential. If you
have any questions, please contact the ACP/AANP Research Department by email at
or phone at .
This survey will take approximately 12 minutes.